Ioflupane I-123
Alternative Names: DaTSCAN; DaTscan; Ioflupane (123I); Radio-labelled ioflupane; β-CIT-FPLatest Information Update: 09 Nov 2022
At a glance
- Originator GE Healthcare
- Class Diagnostic agents; Nortropanes; Small molecules
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Dementia; Lewy body disease; Multiple system atrophy; Parkinsonian disorders; Progressive supranuclear palsy
- Phase III Essential tremor; Parkinson's disease